{"id":"W2890388049","doi":"10.1200/jco.2017.35.15_suppl.3529","title":"Phase 1b/II study of cancer stemness inhibitor napabucasin (BBI-608) in combination with FOLFIRI +/- bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; FOLFIRI; Bevacizumab; Internal medicine; Colorectal cancer; Cancer; Oncology; Combination therapy; Irinotecan; Gastroenterology; Pharmacology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00319868,0.00028133,0.001764376,0.0003037626,0.0002641972,0.00002422723,0.0006206505,0.0003978355,0.0002603493],"category_scores_gemma":[0.0008450465,0.0002142843,0.000205092,0.0002223574,0.0005355958,0.0004159616,0.0001956968,0.001776897,0.000002757411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004189998,"about_ca_system_score_gemma":0.001144168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000717649,"about_ca_topic_score_gemma":0.014193,"domain_scores_codex":[0.9943734,0.001793134,0.002627015,0.0003531218,0.0004406408,0.0004127199],"domain_scores_gemma":[0.9933691,0.001257118,0.004164449,0.000206272,0.0007301108,0.0002729616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01697901,0.07578985,0.7941222,0.00005162123,0.0006727087,0.0004722371,0.001191082,0.0001268221,0.0004934232,0.0000253137,0.0004978893,0.1095778],"study_design_scores_gemma":[0.1447237,0.04021377,0.805439,0.0001908674,0.0005984547,0.00001534473,0.0008155912,0.0006573003,0.0012803,0.0001154526,0.005672251,0.0002779514],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933388,0.0003041275,0.000006605303,0.001261383,0.003886476,0.000849577,0.00005729619,0.000005334596,0.0002904009],"genre_scores_gemma":[0.9986438,0.0004590185,0.00008568825,0.0003597047,0.0002839581,0.00006560441,0.000004282278,0.0000246262,0.00007332561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1277447,"threshold_uncertainty_score":0.873826,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3085729750230846,"score_gpt":0.5868428381078282,"score_spread":0.2782698630847436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}